June 2, 2020
Nihon Servier and Yakult Honsha rolled out its cancer agent Onivyde (liposomal irinotecan) in Japan on June 1 for the treatment of unresectable pancreatic cancer that has progressed following chemotherapy. Onivyde is a formulation of polyethylene glycol (PEG)-modified liposomes encapsulating...read more